Case Studies 1

Prior to launching a first-in-class oncology product into a highly specialized and competitive indication, a client wished to devise a European development strategy that would optimize the value of the asset. Key questions included: how concentrated are clinical stakeholders and how does treatment vary across geographies? How will the competitive environment evolve, and what impact will this have on the commercial opportunity and launch strategy? Easton Associates provided an in-depth, country-by-country assessment of the market potential and critical capabilities needed to drive share, leading to recommendations regarding commercial strategy, organization, clinical development activities, implementation tactics, and near-term investment priorities.